Cytokines in the cerebrospinal fluids of patients with chronic fatigue syndrome/myalgic encephalomyelitis

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Peterson, D ^a   Brenu, E W ^b   Gottschalk, G ^a   Ramos, S ^b   Nguyen, T ^b   Staines, D ^b   Marshall Gradisnik, S ^b  

^a Simmaron Research   (United States)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; CELL ASSAY; CEREBROSPINAL FLUID ANALYSIS; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; INFLAMMATION; PRIORITY JOURNAL; CASE CONTROL STUDY; CEREBROSPINAL FLUID; GENE EXPRESSION REGULATION; METABOLISM; PILOT STUDY;

CASE-CONTROL STUDIES; CEREBROSPINAL FLUID; CYTOKINES; FATIGUE SYNDROME, CHRONIC; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-10; PILOT PROJECTS;

EID: 84925340783     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/929720     Document Type: Article

References (38)

1. W. Wojcik, D. Armstrong, and R. Kanaan, "Is chronic fatigue syndrome a neurological condition? A survey of UK neurologists," Journal of Psychosomatic Research, vol. 70, no. 6, pp. 573-574, 2011.
2. M. Sharpe, "Chronic fatigue syndrome: neurological, mental or both," Journal of Psychosomatic Research, vol. 70, no. 6, pp. 498-499, 2011.
3. W. Brola, M. Ziomek, and J. Czernicki, "Fatigue syndrome in chronic neurological disorders," Neurologia i Neurochirurgia Polska, vol. 41, no. 4, pp. 340-349, 2007.
4. A. Hilgers and J. Frank, "Chronic fatigue syndrome: immune dysfunction, role of pathogens and toxic agents and neurological and cardial changes," Wiener Medizinische Wochenschrift, vol. 144, no. 16, pp. 399-406, 1994.
5. D. Neu, O. Mairesse, X. Montana et al., "Dimensions of pure chronic fatigue: psychophysical, cognitive and biological correlates in the chronic fatigue syndrome," European Journal of Applied Physiology, vol. 114, pp. 1841-1851, 2014.
6. S. J. Cockshell and J. L. Mathias, "Cognitive functioning in people with chronic fatigue syndrome: a comparison between subjective and objectivemeasures," Neuropsychology, vol. 28, no. 3, pp. 394-405, 2014.
7. E. A. Attree, M. A. Arroll, C. P. Dancey, C. Griffith, and A. S. Bansal, "Psychosocial factors involved in memory and cognitive failures in people with myalgic encephalomyelitis/chronic fatigue syndrome," Psychology Research and Behavior Management, vol. 7, pp. 67-76, 2014.
8. E.W. Brenu, T. K. Huth, S. L. Hardcastle et al., "Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis," International Immunology, vol. 26, no. 4, pp. 233-242, 2014.
9. E. W. Brenu, M. L. van Driel, D. R. Staines et al., "Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis," Journal of Translational Medicine, vol. 9, article 81, 2011.
10. E. W. Brenu, D. R. Staines, O. K. Baskurt et al., "Immune and hemorheological changes in chronic fatigue syndrome," Journal of Translational Medicine, vol. 8, article 1, 2010.
11. A. T. White, A. R. Light, R. W. Hughen et al., "Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome," Psychophysiology, vol. 47, no. 4, pp. 615-624, 2010.
12. M. A. Fletcher, X. R. Zeng, Z. Barnes, S. Levis, and N. G. Klimas, "Plasma cytokines in women with chronic fatigue syndrome," Journal of Translational Medicine, vol. 7, article 96, 2009.
13. E.W. Brenu, M. L. van Driel, D. R. Staines et al., "Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis," Journal of Translational Medicine, vol. 10, no. 1, article 88, 2012.
14. T. Nakamura, S. K. Schwander, R. Donnelly et al., "Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia," Clinical and Vaccine Immunology, vol. 17, no. 4, pp. 582-587, 2010.
15. R. Patarca, "Cytokines and chronic fatigue syndrome," Annals of the New York Academy of Sciences, vol. 933, pp. 185-200, 2001.
16. D. Sredni-Kenigsbuch, "TH1/TH2 cytokines in the central nervous system," International Journal of Neuroscience, vol. 112, no. 6, pp. 665-703, 2002.
17. C. X. Wang and A. Shuaib, "Involvement of inflammatory cytokines in central nervous system injury," Progress in Neurobiology, vol. 67, no. 2, pp. 161-172, 2002.
18. J. Szelényi, "Cytokines and the central nervous system," Brain Research Bulletin, vol. 54, no. 4, pp. 329-338, 2001.
19. Y. Sei, L. Vitkovic, and M. M. Yokoyama, "Cytokines in the central nervous system: regulatory roles in neuronal function, cell death and repair," Neuro Immuno Modulation, vol. 2, no. 3, pp. 121-133, 1995.
20. U.-K. Hanisch, "Microglia as a source and target of cytokines," Glia, vol. 40, no. 2, pp. 140-155, 2002.
21. Y. B. Lee, A. Nagai, and S. U. Kim, "Cytokines, chemokines, and cytokine receptors in human microglia," Journal of Neuroscience Research, vol. 69, no. 1, pp. 94-103, 2002.
22. Q. Fu, J. Zhu, and J. E. van Eyk, "Comparison of multiplex immunoassay platforms," Clinical Chemistry, vol. 56, no. 2, pp. 314-318, 2010.
23. A. Chan, T. Magnus, and R. Gold, "Phagocytosis of apoptotic inflammatory cells by microglia and modulation by different cytokines: mechanism for removal of apoptotic cells in the inflamed nervous system," Glia, vol. 33, no. 1, pp. 87-95, 2001.
24. D. Giulian, J. Li, X. Li, J. George, and P. A. Rutecki, "The impact of microglia-derived cytokines upon gliosis in the CNS," Developmental Neuroscience, vol. 16, no. 3-4, pp. 128-136, 1994.
25. A. Suzumura, M. Sawada, K. Mokuno, K. Kato, T. Marunouchi, and H. Yamamoto, "Effects of microglia-derived cytokines on astrocyte proliferation," Restorative Neurology and Neuroscience, vol. 5, no. 5-6, pp. 347-352, 1993.
26. M. Howard, A. O'Garra, H. Ishida, R. de Waal Malefyt, and J. de Vries, "Biological properties of interleukin 10," Journal of Clinical Immunology, vol. 12, no. 4, pp. 239-247, 1992.
27. S. Chabot, G. Williams, M. Hamilton, G. Sutherland, and V.W. Yong, "Mechanisms of IL-10 production in human microglia-T cell interaction," Journal of Immunology, vol. 162, no. 11, pp. 6819-6828, 1999.
28. B. M. Iglesias, J. Cerase, C. Ceracchini, G. Levi, and F. Aloisi, "Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-gamma and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents," Journal of Neuroimmunology, vol. 72, no. 1, pp. 83-93, 1997.
29. R. Wei and G. M. Jonakait, "Neurotrophins and the antiinflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia," Journal of Neuroimmunology, vol. 95, no. 1-2, pp. 8-18, 1999.
30. C. A. Akdis, A. Joss, M. Akdis, and K. Blaser, "Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens," International Archives of Allergy and Immunology, vol. 124, no. 1-3, pp. 180-182, 2001.
31. K. Strle, J.-H. Zhou, W.-H. Shen et al., "Interleukin-10 in the brain," Critical Reviews in Immunology, vol. 21, no. 5, pp. 427-449, 2001.
32. C. M. Hedrich and J. H. Bream, "Cell type-specific regulation of IL-10 expression in inflammation and disease," Immunologic Research, vol. 47, no. 1-3, pp. 185-206, 2010.
33. K. Williams, N. Dooley, E. Ulvestad, B. Becher, and J. P. Antel, "IL-10 production by adult human derived microglial cells," Neurochemistry International, vol. 29, no. 1, pp. 55-64, 1996.
34. C. Dong, R. J. Davis, and R. A. Flavell, "Signaling by the JNK group of MAP kinases. c-jun N-terminal Kinase," Journal of Clinical Immunology, vol. 21, no. 4, pp. 253-257, 2001.
35. E. E. V. Jesus, A. M. Pinheiro, A. B. Santos et al., "Effects of IFNgamma, TNF-alpha, IL-10 and TGF-beta on Neospora caninum infection in rat glial cells," Experimental Parasitology, vol. 133, no. 3, pp. 269-274, 2013.
36. M. Sawada, A. Suzumura, H. Hosoya, T. Marunouchi, and T. Nagatsu, "Interleukin-10 inhibits both production of cytokines and expression of cytokine receptors in microglia," Journal of Neurochemistry, vol. 72, no. 4, pp. 1466-1471, 1999.
37. B.H. Natelson, S. A. Weaver, C.-L. Tseng, and J. E. Ottenweller, "Spinal fluid abnormalities in patients with chronic fatigue syndrome," Clinical and Diagnostic Laboratory Immunology, vol. 12, no. 1, pp. 52-55, 2005.
38. A. S. Bansal, A. S. Bradley, K. N. Bishop, S. Kiani-Alikhan, and B. Ford, "Chronic fatigue syndrome, the immune system and viral infection," Brain, Behavior, and Immunity, vol. 26, no. 1, pp. 24-31, 2012.